Could New Technology End Auto Pedestrian Accidents?
According to the Centers for Disease Control and Prevention, in 2013 over 150,000 pedestrians were treated in emergency rooms for injuries caused by auto pedestrian collisions, and over 4,700 pedestrians were killed in these accidents. The frequency and severity of auto pedestrian accidents inspired car manufacturers to find new technologies to keep everyone on the road safe, and one manufacturer has widely instituted new technology that might bring an end to auto pedestrian accidents.
Federal Working Hour Regulations For Truck Drivers
Although we share the roads with them every day, truck drivers are not treated the same as other motorists under federal law. Because 18-wheelers and other large trucks have the potential to cause catastrophic injuries in the event of an accident, all truck drivers must abide by Federal Motor Carrier Safety Administration (FMCSA) regulations. Many FMCSA regulations set restrictions on working hours for truck drivers to prevent them from driving while fatigued.
First Transvaginal Mesh Case Finally Over
The first transvaginal mesh case to go to trial has finally come to a conclusion. The plaintiff was a South Dakota woman named Linda Gross who experienced severe complications from the transvaginal mesh product she had implanted. Although Ms. Gross’s trial concluded in 2013, device manufacturer defendants Johnson & Johnson and Ethicon fought the verdict for over three years. However, the Supreme Court of New Jersey declined to hear an appeal from the manufacturers, allowing the original jury verdict to stand.
IVC Filter Litigation Update
There are currently thousands of lawsuits pending against nearly a dozen IVC filter manufacturers across the country. Patients harmed by defective IVC filters have been patiently waiting for their day in court and the new year will see at least two IVC filter cases to go to trial.
What To Know About Raising A Child With Birth Defects
Every year, over 120,000 babies are born with birth defects. While there could be many causes of birth defects, many are caused by the exposure of the fetus to certain prescription medications in utero. For pregnant mothers, certain anti-depressants like Celexa, Lexapro, and Zoloft can cause their unborn children to develop birth defects.
Commonly Misdiagnosed Ovarian Cancer Symptoms
In light of several multimillion-dollar trial verdicts this year against healthcare giant Johnson & Johnson (J&J), consumers have become aware of the dangerous link between the talc in J&J’s baby powder products and ovarian cancer. Thousands of women across the country filed lawsuits against the company alleging J&J failed to warn them of the risk of ovarian cancer associated with its products.
Ten Tips For Preventing Auto Pedestrian Accidents
Even at low speeds, auto pedestrian accidents can cause serious injuries or even death. Because pedestrians do not have any protection in the event of a collision, drivers need to do everything in their power to prevent auto pedestrian accidents.
What’s Next For The Talcum Powder Litigation?
After the fourth baby powder trial resulted in a $70 million win for the plaintiff, thousands of other baby powder cancer plaintiffs eagerly await their day in court. Although it will be some time before the next baby powder lawsuit goes to trial, the litigation as a whole will be taking some big steps in the coming months.
6 Things To Know About 18-Wheeler Accidents
Although 18-wheelers and other commercial vehicles are crucial to our economy and way of life, large trucks pose some unique risks to anyone they share the roadway with. Their large size and huge weight means accidents involving 18-wheelers usually cause much more severe injuries than other types of motor vehicle accidents.
Zofran Birth Defects Litigation Update
For more than 300 families in the Zofran litigation, the process has been incredibly slow and pharmaceutical giant GlaxoSmithKline (GSK) has fought the allegations at every turn. Despite the pace, the litigation has slowly moved forward and is getting closer to a trial date.